LEXX
Lexaria Bioscience Corp.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
8
Buys
7
Sells
1
Largest Trade
$100K–$500K
Insiders
6
Institutional Funds
15
Inst. Value
$500K+
Activist Filings
3
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director | BUY | $15K–$50K | 28K | $0.92 | Jul 30, 2025 |
| McKechnie William Edward | Director | BUY | $1K–$15K | 5K | $0.91 | Jul 30, 2025 |
| DOCHERTY JOHN MARTIN | President & CSO | BUY | $1K–$15K | 5K | $0.93 | Jul 30, 2025 |
| Carle Vanessa | Secretary | BUY | <$1K | 750 | $0.91 | Jul 30, 2025 |
| CHRISTOPHER RICHARD | CEO | BUY | $1K–$15K | 15K | $0.91 | Jul 30, 2025 |
| CHRISTOPHER RICHARD | CEO | BUY | $100K–$500K | 50K | $2.37 | Dec 3, 2024 |
| Carle Vanessa | Secretary | SELL | $1K–$15K | 3K | $4.00 | Aug 1, 2024 |
| TURKEL CATHERINE C. | Director | BUY | $1K–$15K | 2K | $2.84 | Feb 27, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 15 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| UBS Group AG | 345K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 184K | $100K–$500K | SH |
| VANGUARD GROUP INC | 154K | $50K–$100K | SH |
| Byrne Asset Management LLC | 106K | $50K–$100K | SH |
| STATE STREET CORP | 39K | $15K–$50K | SH |
| BlackRock, Inc. | 27K | $15K–$50K | SH |
| Krilogy Financial LLC | 20K | $15K–$50K | SH |
| RENAISSANCE TECHNOLOGIES LLC | 16K | $1K–$15K | SH |
| BANK OF MONTREAL /CAN/ | 14K | $1K–$15K | SH |
| Federation des caisses Desjardins du Quebec | 382 | <$1K | SH |
| MAI Capital Management | 200 | <$1K | SH |
| Farther Finance Advisors, LLC | 166 | <$1K | SH |
| TORONTO DOMINION BANK | 13 | <$1K | SH |
| GABLES CAPITAL MANAGEMENT INC. | 13 | <$1K | SH |
| MORGAN STANLEY | 3 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Invenomic Capital Management LP
SC 13G/A · Nov 14, 2024
4.7%
568K shares
Invenomic Capital Management LP
SC 13G/A · Feb 14, 2024
7.1%
732K shares
L1 Capital Global Opportunities Master Fund Ltd.
SC 13G/A · Feb 11, 2022
2.6%
159K shares